Country: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
DESVENLAFAXINE
SANIS HEALTH INC
N06AX23
DESVENLAFAXINE
50MG
TABLET (EXTENDED-RELEASE)
DESVENLAFAXINE 50MG
ORAL
15G/50G
Prescription
Active ingredient group (AIG) number: 0152509001; AHFS:
APPROVED
2023-02-06
_ _ _DESVENLAFAXINE PRODUCT MONOGRAPH PAGE 1 OF 51 _ PRODUCT MONOGRAPH PR DESVENLAFAXINE Desvenlafaxine Extended-Release Tablets Extended-release tablets, 50 mg and 100 mg Desvenlafaxine, Oral Antidepressant SANIS HEALTH INC. 1 PRESIDENT'S CHOICE CIRCLE BRAMPTON, ONTARIO L6Y 5S5 SUBMISSION CONTROL NUMBER: 270697 DATE OF PREPARATION: FEB 06, 2023 _ _ _DESVENLAFAXINE PRODUCT MONOGRAPH PAGE 2 OF 51 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS ........................................................................................................... 4 WARNINGS AND PRECAUTIONS ......................................................................................... 4 ADVERSE REACTIONS ......................................................................................................... 11 DRUG INTERACTIONS ......................................................................................................... 21 DOSAGE AND ADMINISTRATION ..................................................................................... 24 OVERDOSAGE ........................................................................................................................ 26 ACTION AND CLINICAL PHARMACOLOGY .................................................................... 28 STORAGE AND STABILITY ................................................................................................. 31 SPECIAL HANDLING INSTRUCTIONS ............................................................................... 31 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................... 31 PART II: SCIENTIFIC INFORMATION ............................................................................... 33 P সম্পূর্ণ নথি পড়ুন